<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="26333">Prostaglandin</z:chebi> E(2) (<z:chebi fb="0" ids="26338">PGE</z:chebi>(2)), the most abundant COX-2-derived <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> found in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, promotes <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell proliferation and survival via multiple signaling pathways </plain></SENT>
<SENT sid="1" pm="."><plain>However, the role of <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0005039'>hypoxia</z:mp> is not well understood </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show a synergistic effect of <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) and <z:mp ids='MP_0005039'>hypoxia</z:mp> on enhancing angiopoietin-like protein 4 (ANGPTL4) expression and that elevation of ANGPTL4 promotes <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> growth </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="26338">PGE</z:chebi>(2) induces ANGPTL4 expression at both the <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein levels under hypoxic conditions </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, <z:mp ids='MP_0005039'>hypoxia</z:mp> induces one of the <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) receptors, namely EP1 </plain></SENT>
<SENT sid="5" pm="."><plain>Activation of EP1 enhances ANGPTL4 expression, whereas blockage of EP1 by an <z:chebi fb="68" ids="48706">antagonist</z:chebi> inhibits <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) induction of ANGPTL4 under hypoxic conditions </plain></SENT>
<SENT sid="6" pm="."><plain>Importantly, overexpression of ANGPTL4 promotes cell proliferation and <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> in vitro and in vivo </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, treatment with ANGPTL4 recombinant protein increases colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> cell proliferation through effects on STAT1 signaling </plain></SENT>
<SENT sid="8" pm="."><plain>The MAP kinase and Src pathways mediate ANGPTL4-induced STAT1 expression and activation </plain></SENT>
<SENT sid="9" pm="."><plain>These results are relevant to human disease because we found that the expression of ANGPTL4 and STAT1 are elevated in 50% of human <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> tested and there is a positive correlation between COX-2 and ANGPTL4 as well STAT1 expression in colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="10" pm="."><plain>Collectively, these findings suggest that <z:chebi fb="0" ids="26338">PGE</z:chebi>(2) plays an important role in promoting <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cell proliferation via ANGPTL4 under hypoxic conditions </plain></SENT>
</text></document>